Far East Bio-Tec Co., Ltd.
Far East Bio-Tec Co., Ltd. manufactures and sells organic chlorella, spirulina, and dietary supplements. It also offers nutraceuticals/nutritional supplements, immune booster products, antiviral sprays, and pet supplements. The company was founded in 1976 and is based in Taipei, Taiwan.
Far East Bio-Tec Co., Ltd. (6886) - Net Assets
Latest net assets as of June 2025: NT$552.89 Million TWD
Based on the latest financial reports, Far East Bio-Tec Co., Ltd. (6886) has net assets worth NT$552.89 Million TWD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$688.48 Million) and total liabilities (NT$135.59 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$552.89 Million |
| % of Total Assets | 80.31% |
| Annual Growth Rate | 7.11% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 9.22 |
Far East Bio-Tec Co., Ltd. - Net Assets Trend (2020–2024)
This chart illustrates how Far East Bio-Tec Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Far East Bio-Tec Co., Ltd. (2020–2024)
The table below shows the annual net assets of Far East Bio-Tec Co., Ltd. from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$513.79 Million | +5.15% |
| 2023-12-31 | NT$488.62 Million | +13.24% |
| 2022-12-31 | NT$431.51 Million | +18.00% |
| 2021-12-31 | NT$365.70 Million | -6.32% |
| 2020-12-31 | NT$390.39 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Far East Bio-Tec Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 103.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$83.07 Million | 16.17% |
| Common Stock | NT$291.90 Million | 56.81% |
| Other Components | NT$138.83 Million | 27.02% |
| Total Equity | NT$513.79 Million | 100.00% |
Far East Bio-Tec Co., Ltd. Competitors by Market Cap
The table below lists competitors of Far East Bio-Tec Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
KINGDEE INTL SOFTWA
BE:KDIC
|
$14.64K |
|
Hortico S.A.
WAR:HOR
|
$14.66K |
|
UNITIKA
BE:UTN
|
$14.68K |
|
Suno Fazendas Fiagro – Imobiliario
SA:SNFZ11
|
$14.69K |
|
Core AI Holdings
NASDAQ:CHAI
|
$14.63K |
|
Eleco PLC
LSE:ELCO
|
$14.62K |
|
Eureka Capital Corp.
V:EBCD-P
|
$14.62K |
|
CASI PHARMAC. NEW O.N.
F:ENM
|
$14.61K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Far East Bio-Tec Co., Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 488,625,000 to 513,794,000, a change of 25,169,000 (5.2%).
- Net income of 52,495,000 contributed positively to equity growth.
- Dividend payments of 27,800,000 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$52.49 Million | +10.22% |
| Dividends Paid | NT$27.80 Million | -5.41% |
| Other Changes | NT$474.00K | +0.09% |
| Total Change | NT$- | 5.15% |
Book Value vs Market Value Analysis
This analysis compares Far East Bio-Tec Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.85x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.94x to 2.85x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | NT$12.69 | NT$50.00 | x |
| 2021-12-31 | NT$12.29 | NT$50.00 | x |
| 2022-12-31 | NT$17.21 | NT$50.00 | x |
| 2023-12-31 | NT$16.95 | NT$50.00 | x |
| 2024-12-31 | NT$17.54 | NT$50.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Far East Bio-Tec Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.22%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 13.54%
- • Asset Turnover: 0.60x
- • Equity Multiplier: 1.25x
- Recent ROE (10.22%) is below the historical average (11.21%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 10.24% | 13.59% | 0.60x | 1.25x | NT$943.20K |
| 2021 | 8.99% | 10.32% | 0.69x | 1.27x | NT$-3.69 Million |
| 2022 | 21.01% | 23.88% | 0.70x | 1.26x | NT$47.51 Million |
| 2023 | 5.61% | 8.95% | 0.54x | 1.17x | NT$-21.47 Million |
| 2024 | 10.22% | 13.54% | 0.60x | 1.25x | NT$1.12 Million |
Industry Comparison
This section compares Far East Bio-Tec Co., Ltd.'s net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $17,559,023,800
- Average return on equity (ROE) among peers: 8.12%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Far East Bio-Tec Co., Ltd. (6886) | NT$552.89 Million | 10.24% | 0.25x | $14.64K |
| Wei Chuan Foods Corp (1201) | $5.55 Billion | 12.34% | 1.69x | $125.16 Million |
| Ve Wong Corp (1203) | $6.25 Billion | 7.16% | 0.53x | $76.18 Million |
| Great Wall Enterprise Co Ltd (1210) | $7.57 Billion | 10.72% | 1.28x | $893.11 Million |
| Charoen Pokphand Enterprise Taiwan Co Ltd (1215) | $5.36 Billion | 14.61% | 0.75x | $839.68 Million |
| Uni-President Enterprises Corp (1216) | $130.79 Billion | 9.49% | 1.59x | $10.01 Billion |
| AGV Products Corp (1217) | $6.27 Billion | 0.76% | 1.01x | $116.99 Million |
| Taisun Enterprise Co Ltd (1218) | $3.67 Billion | 6.42% | 1.09x | $108.34 Million |
| Fwusow Industry Co Ltd (1219) | $3.96 Billion | 5.13% | 1.26x | $99.99 Million |
| Tai Roun Products Co Ltd (1220) | $2.53 Billion | 5.26% | 0.26x | $37.61 Million |
| Formosa Oilseed Processing Co Ltd (1225) | $3.65 Billion | 9.29% | 1.12x | $49.69 Million |